Your browser doesn't support javascript.
loading
Structure of lipoprotein lipase in complex with GPIHBP1.
Arora, Rishi; Nimonkar, Amitabh V; Baird, Daniel; Wang, Chunhua; Chiu, Chun-Hao; Horton, Patricia A; Hanrahan, Susan; Cubbon, Rose; Weldon, Stephen; Tschantz, William R; Mueller, Sascha; Brunner, Reto; Lehr, Philipp; Meier, Peter; Ottl, Johannes; Voznesensky, Andrei; Pandey, Pramod; Smith, Thomas M; Stojanovic, Aleksandar; Flyer, Alec; Benson, Timothy E; Romanowski, Michael J; Trauger, John W.
Afiliação
  • Arora R; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Nimonkar AV; Cardiovascular and Metabolic Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Baird D; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Wang C; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Chiu CH; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Horton PA; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Hanrahan S; Cardiovascular and Metabolic Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Cubbon R; Cardiovascular and Metabolic Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Weldon S; Biotherapeutic and Analytical Technologies, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Tschantz WR; Biotherapeutic and Analytical Technologies, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Mueller S; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.
  • Brunner R; Chemical Biology and Therapeutics, 4002 Basel, Switzerland.
  • Lehr P; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.
  • Meier P; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.
  • Ottl J; Chemical Biology and Therapeutics, 4002 Basel, Switzerland.
  • Voznesensky A; Biotherapeutic and Analytical Technologies, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Pandey P; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Smith TM; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Stojanovic A; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.
  • Flyer A; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Benson TE; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
  • Romanowski MJ; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139; michael.romanowski@novartis.com john.trauger@novartis.com.
  • Trauger JW; Cardiovascular and Metabolic Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA 02139; michael.romanowski@novartis.com john.trauger@novartis.com.
Proc Natl Acad Sci U S A ; 116(21): 10360-10365, 2019 05 21.
Article em En | MEDLINE | ID: mdl-31072929
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Lipoproteínas / Lipase Lipoproteica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Lipoproteínas / Lipase Lipoproteica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2019 Tipo de documento: Article